Patents by Inventor Jeffrey W. Almond

Jeffrey W. Almond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Attenuated polioviruses
    Patent number: 5298413
    Abstract: An attenuated enterovirus or rhinovirus, suitable for use as a vaccine, has an attenuating mutation at least at a position which is, or corresponds with, position 471 or 484 of the genome of poliovirus type 3 Leon strain.
    Type: Grant
    Filed: May 17, 1993
    Date of Patent: March 29, 1994
    Assignee: British Technology Group Limited
    Inventors: Jeffrey W. Almond, Philip D. Minor, Michael A. Skinner
  • Attenuated polioviruses
    Patent number: 5298416
    Abstract: An attenuated enterovirus or rhinovirus, suitable for use as a vaccine, has a reversed base pairing in the part, or in a part corresponding to the part, of the 5' non-coding region of the genome of poliovirus type 3 Leon strain shown below: ##STR1## A suitable attenuated poliovirus has the bases G and C at positions 469 and 534 respectively for a type 1 or type 2 poliovirus or at positions 472 and 537 respectively for a type 3 poliovirus.
    Type: Grant
    Filed: May 17, 1993
    Date of Patent: March 29, 1994
    Assignee: British Technology Group Ltd.
    Inventors: Jeffrey W. Almond, Philip D. Minor, Michael A. Skinner, Colin R. Young
  • Attenuated polioviruses
    Patent number: 5286640
    Abstract: An attenuated enterovirus or rhinovirus, suitable for use as a vaccine, has an attenuating mutation at least at a position which is, or corresponds with, position 479 and/or 482 of poliovirus type 3 Leon strain.
    Type: Grant
    Filed: May 17, 1993
    Date of Patent: February 15, 1994
    Inventors: Jeffrey W. Almond, Michael A. Skinner, Vincent Racaniello, Philip D. Minor
  • Peptides useful in vaccination against enteroviruses
    Patent number: 4857634
    Abstract: A synthetic peptide, suitable for use in vaccination against or diagnosis of a disease caused by an enterovirus and especially by a poliovirus, is the peptide coded for by codons 286-290 in the RNA sequence coding for the structural capsid protein VP1 of poliovirus type 3 Sabin strain or by equivalent codons of another enterovirus or is an antigenic equivalent thereof, the numbers of the codons being counted from the 5'-terminus of the nucleotide sequence coding for the VP1 capsid protein.
    Type: Grant
    Filed: August 24, 1987
    Date of Patent: August 15, 1989
    Assignee: National Research Development Corporation
    Inventors: Philip D. Minor, David M. A. Evans, Geoffrey C. Schild, Jeffrey W. Almond, Morag Ferguson
  • Polypeptides useful in vaccination against enteroviruses
    Patent number: 4810491
    Abstract: A synthetic polypeptide, suitable for use in vaccination against or diagnosis of a disease caused by an enterovirus, is an octapeptide coded for by codons 93-100 in the RNA sequence coded for the structural capsid protein VP1 for poliovirus type 3 Sabin strain or by equivalent codons of another enterovirus or is an antigenic equivalent of such an octapeptide, the numbers of the codons being counted from the 5'-terminus of the nucleotide sequence for the VP1 capsid protein.
    Type: Grant
    Filed: July 2, 1987
    Date of Patent: March 7, 1989
    Assignee: National Research Development Corporation
    Inventors: Philip D. Minor, David M. A. Evans, Geoffrey C. Schild, Jeffrey W. Almond
  • Polypeptides useful in vaccination against enteroviruses
    Patent number: 4694071
    Abstract: A synthetic polypeptide, suitable for use in vaccination against or diagnosis of a disease caused by an enterovirus, is an octapeptide coded for by codons 93-100 in the RNA sequence coded for the structural capsid protein VP1 for poliovirus type 3 Sabin strain or by equivalent codons of another enterovirus or is an antigenic equivalent of such an octapeptide, the numbers of the codons being counted from the 5'-terminus of the nucleotide sequence for the VP1 capsid protein.
    Type: Grant
    Filed: June 8, 1984
    Date of Patent: September 15, 1987
    Assignee: National Research Development Corporation
    Inventors: Jeffrey W. Almond, Phillip D. Minor, David M. A. Evans, Geoffrey C. Schild